vs

Side-by-side financial comparison of GRID DYNAMICS HOLDINGS, INC. (GDYN) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

GRID DYNAMICS HOLDINGS, INC. is the larger business by last-quarter revenue ($106.2M vs $83.1M, roughly 1.3× PROCEPT BioRobotics Corp). GRID DYNAMICS HOLDINGS, INC. runs the higher net margin — 0.3% vs -38.1%, a 38.3% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs 5.9%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 15.3%).

Escape Dynamics, Inc. was a Colorado-based technology company that operated 2010–2015 focused on bringing to market single-stage-to-orbit reusable electromagnetically powered spaceplanes.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

GDYN vs PRCT — Head-to-Head

Bigger by revenue
GDYN
GDYN
1.3× larger
GDYN
$106.2M
$83.1M
PRCT
Growing faster (revenue YoY)
PRCT
PRCT
+14.3% gap
PRCT
20.2%
5.9%
GDYN
Higher net margin
GDYN
GDYN
38.3% more per $
GDYN
0.3%
-38.1%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
15.3%
GDYN

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
GDYN
GDYN
PRCT
PRCT
Revenue
$106.2M
$83.1M
Net Profit
$306.0K
$-31.6M
Gross Margin
34.0%
64.9%
Operating Margin
0.5%
-4.1%
Net Margin
0.3%
-38.1%
Revenue YoY
5.9%
20.2%
Net Profit YoY
-93.2%
-27.9%
EPS (diluted)
$0.01
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GDYN
GDYN
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$106.2M
$76.4M
Q3 25
$104.2M
$83.3M
Q2 25
$101.1M
$79.2M
Q1 25
$100.4M
$69.2M
Q4 24
$100.3M
$68.2M
Q3 24
$87.4M
$58.4M
Q2 24
$83.0M
$53.4M
Net Profit
GDYN
GDYN
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$306.0K
$-29.8M
Q3 25
$1.2M
$-21.4M
Q2 25
$5.3M
$-19.6M
Q1 25
$2.9M
$-24.7M
Q4 24
$4.5M
$-18.9M
Q3 24
$4.3M
$-21.0M
Q2 24
$-817.0K
$-25.6M
Gross Margin
GDYN
GDYN
PRCT
PRCT
Q1 26
64.9%
Q4 25
34.0%
60.6%
Q3 25
33.3%
64.8%
Q2 25
34.1%
65.4%
Q1 25
36.8%
63.9%
Q4 24
36.9%
64.0%
Q3 24
37.4%
63.2%
Q2 24
35.6%
59.0%
Operating Margin
GDYN
GDYN
PRCT
PRCT
Q1 26
-4.1%
Q4 25
0.5%
-40.6%
Q3 25
-0.2%
-27.8%
Q2 25
-0.1%
-28.0%
Q1 25
-2.0%
-39.7%
Q4 24
1.3%
-28.9%
Q3 24
2.4%
-38.4%
Q2 24
0.0%
-50.3%
Net Margin
GDYN
GDYN
PRCT
PRCT
Q1 26
-38.1%
Q4 25
0.3%
-39.1%
Q3 25
1.1%
-25.7%
Q2 25
5.2%
-24.7%
Q1 25
2.9%
-35.8%
Q4 24
4.5%
-27.6%
Q3 24
4.9%
-35.9%
Q2 24
-1.0%
-48.0%
EPS (diluted)
GDYN
GDYN
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$0.01
$-0.54
Q3 25
$0.01
$-0.38
Q2 25
$0.06
$-0.35
Q1 25
$0.03
$-0.45
Q4 24
$0.06
$-0.34
Q3 24
$0.05
$-0.40
Q2 24
$-0.01
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GDYN
GDYN
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$342.1M
$245.6M
Total DebtLower is stronger
$51.7M
Stockholders' EquityBook value
$542.1M
$347.7M
Total Assets
$612.9M
$487.1M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GDYN
GDYN
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$342.1M
$286.5M
Q3 25
$338.6M
$294.3M
Q2 25
$336.8M
$302.7M
Q1 25
$325.5M
$316.2M
Q4 24
$334.7M
$333.7M
Q3 24
$231.3M
$196.8M
Q2 24
$256.0M
$214.1M
Total Debt
GDYN
GDYN
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
GDYN
GDYN
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$542.1M
$365.9M
Q3 25
$537.7M
$380.3M
Q2 25
$532.2M
$385.8M
Q1 25
$517.4M
$389.2M
Q4 24
$517.8M
$402.2M
Q3 24
$400.2M
$241.2M
Q2 24
$388.4M
$251.8M
Total Assets
GDYN
GDYN
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$612.9M
$508.1M
Q3 25
$613.2M
$511.5M
Q2 25
$608.9M
$513.1M
Q1 25
$590.9M
$519.4M
Q4 24
$592.2M
$534.0M
Q3 24
$477.3M
$374.1M
Q2 24
$443.6M
$374.4M
Debt / Equity
GDYN
GDYN
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GDYN
GDYN
PRCT
PRCT
Operating Cash FlowLast quarter
$9.9M
Free Cash FlowOCF − Capex
$6.1M
FCF MarginFCF / Revenue
5.7%
Capex IntensityCapex / Revenue
3.6%
Cash ConversionOCF / Net Profit
32.34×
TTM Free Cash FlowTrailing 4 quarters
$25.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GDYN
GDYN
PRCT
PRCT
Q1 26
Q4 25
$9.9M
$-10.3M
Q3 25
$7.0M
$-6.6M
Q2 25
$14.4M
$-15.0M
Q1 25
$9.4M
$-17.0M
Q4 24
$7.1M
$-32.4M
Q3 24
$9.2M
$-18.8M
Q2 24
$10.7M
$-15.7M
Free Cash Flow
GDYN
GDYN
PRCT
PRCT
Q1 26
Q4 25
$6.1M
$-12.2M
Q3 25
$2.9M
$-9.5M
Q2 25
$10.2M
$-17.8M
Q1 25
$6.0M
$-18.8M
Q4 24
$4.4M
$-33.6M
Q3 24
$5.9M
$-19.0M
Q2 24
$8.0M
$-16.8M
FCF Margin
GDYN
GDYN
PRCT
PRCT
Q1 26
Q4 25
5.7%
-15.9%
Q3 25
2.8%
-11.4%
Q2 25
10.1%
-22.5%
Q1 25
6.0%
-27.2%
Q4 24
4.4%
-49.2%
Q3 24
6.8%
-32.6%
Q2 24
9.7%
-31.4%
Capex Intensity
GDYN
GDYN
PRCT
PRCT
Q1 26
Q4 25
3.6%
2.4%
Q3 25
3.9%
3.4%
Q2 25
4.1%
3.5%
Q1 25
3.3%
2.7%
Q4 24
2.6%
1.7%
Q3 24
3.7%
0.4%
Q2 24
3.2%
2.0%
Cash Conversion
GDYN
GDYN
PRCT
PRCT
Q1 26
Q4 25
32.34×
Q3 25
5.92×
Q2 25
2.73×
Q1 25
3.21×
Q4 24
1.56×
Q3 24
2.15×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GDYN
GDYN

Other$30.6M29%
Technology Media And Telecom$30.1M28%
Financial Service$24.3M23%
Manufactured Product Other$10.8M10%
Related Party$7.6M7%
Health Care$2.8M3%

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons